162 related articles for article (PubMed ID: 30773177)
1. Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy.
Li PC; Liebsch NJ; Niemierko A; Giantsoudi D; Lessell S; Fullerton BC; Adams J; Shih HA
Radiother Oncol; 2019 Feb; 131():112-119. PubMed ID: 30773177
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced optic neuropathy after pencil beam scanning proton therapy for skull-base and head and neck tumours.
Kountouri M; Pica A; Walser M; Albertini F; Bolsi A; Kliebsch U; Bachtiary B; Combescure C; Lomax AJ; Schneider R; Weber DC
Br J Radiol; 2020 Mar; 93(1107):20190028. PubMed ID: 31322969
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT).
Brecht S; Boda-Heggemann J; Budjan J; Siebenlist K; Stieler F; Steil V; Wenz F; Lohr F; Buergy D
Radiother Oncol; 2019 May; 134():166-177. PubMed ID: 31005211
[TBL] [Abstract][Full Text] [Related]
4. Combining Clinical and Dosimetric Features in a PBS Proton Therapy Cohort to Develop a NTCP Model for Radiation-Induced Optic Neuropathy.
Köthe A; van Luijk P; Safai S; Kountouri M; Lomax AJ; Weber DC; Fattori G
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):587-595. PubMed ID: 33421557
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance.
Stieb S; Snider JW; Placidi L; Kliebsch U; Lomax AJ; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):218-225. PubMed ID: 29029887
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for radiation-induced optic neuropathy: a case-control study.
Ferguson I; Huecker J; Huang J; McClelland C; Van Stavern G
Clin Exp Ophthalmol; 2017 Aug; 45(6):592-597. PubMed ID: 28181362
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Occurrence of Radiation-induced Optic Neuropathy at "Safe" Radiation Dosage.
Doroslovački P; Tamhankar MA; Liu GT; Shindler KS; Ying GS; Alonso-Basanta M
Semin Ophthalmol; 2018; 33(4):581-588. PubMed ID: 28704158
[TBL] [Abstract][Full Text] [Related]
8. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull.
Santoni R; Liebsch N; Finkelstein DM; Hug E; Hanssens P; Goitein M; Smith AR; O'Farrell D; Efird JT; Fullerton B; Munzenrider JE
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):59-68. PubMed ID: 9588918
[TBL] [Abstract][Full Text] [Related]
9. Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery.
Leavitt JA; Stafford SL; Link MJ; Pollock BE
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):524-7. PubMed ID: 24074926
[TBL] [Abstract][Full Text] [Related]
10. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves.
Demizu Y; Murakami M; Miyawaki D; Niwa Y; Akagi T; Sasaki R; Terashima K; Suga D; Kamae I; Hishikawa Y
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1487-92. PubMed ID: 19345516
[TBL] [Abstract][Full Text] [Related]
12. Does altered fractionation influence the risk of radiation-induced optic neuropathy?
Bhandare N; Monroe AT; Morris CG; Bhatti MT; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1070-7. PubMed ID: 15990010
[TBL] [Abstract][Full Text] [Related]
13. Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.
Milano MT; Grimm J; Soltys SG; Yorke E; Moiseenko V; Tomé WA; Sahgal A; Xue J; Ma L; Solberg TD; Kirkpatrick JP; Constine LS; Flickinger JC; Marks LB; El Naqa I
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):87-99. PubMed ID: 29534899
[TBL] [Abstract][Full Text] [Related]
14. Delayed optic nerve complications after proton beam irradiation.
Chacko JG; Schatz NJ; Glaser JS
Ann Ophthalmol (Skokie); 2008; 40(3-4):166-70. PubMed ID: 19230355
[TBL] [Abstract][Full Text] [Related]
15. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors.
Parsons JT; Bova FJ; Fitzgerald CR; Mendenhall WM; Million RR
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):755-63. PubMed ID: 7960976
[TBL] [Abstract][Full Text] [Related]
16. Radiation induced optic neuropathy: Does treatment modality influence the risk?
Mohamed Ali A; Mathis T; Bensadoun RJ; Thariat J
Bull Cancer; 2019 Dec; 106(12):1160-1176. PubMed ID: 31757405
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced optic neuropathy.
Danesh-Meyer HV
J Clin Neurosci; 2008 Feb; 15(2):95-100. PubMed ID: 18068989
[TBL] [Abstract][Full Text] [Related]
18. Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma.
De Leo AN; Holtzman AL; Ho MW; Morris CG; Rutenberg MS; Rotondo RL; Bates JE; Indelicato DJ; Rao D; Asa Hasan M; Mendenhall WM
Radiother Oncol; 2021 May; 158():125-130. PubMed ID: 33610625
[TBL] [Abstract][Full Text] [Related]
19. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
Gillmann C; Jäkel O; Schlampp I; Karger CP
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
[TBL] [Abstract][Full Text] [Related]
20. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
